Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: A randomized clinical trial

Sexually Transmitted Diseases

Volumn 30, Issue 6, 2003, Pages 516-522

  Price, Matthew A ^a   Zimba, Dickman ^b,c   Hoffman, Irving F ^b   Kaydos Daniels, S Cornelia ^a   Miller, William C ^a,b   Martinson, Francis ^c   Chilongozi, David ^c   Kip, Ester ^c   Msowoya, Esnath ^c   Hobbs, Marcia M ^b   Kazembe, Peter N ^c   Cohen, Myron S ^a,b,d  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Lilongwe Central Hospital   (Malawi)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; VIRUS RNA;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALAWI; MALE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STANDARD; SYMPTOM; TREATMENT FAILURE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URETHRITIS; VIRUS TRANSMISSION;

ADMINISTRATION, ORAL; ADULT; ANIMALS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; GENTAMICINS; HIV; HIV INFECTIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALAWI; MALE; METRONIDAZOLE; PREVALENCE; RNA, VIRAL; SEMEN; SYNDROME; TREATMENT OUTCOME; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; URETHRITIS;

EID: 0038278389     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200306000-00009     Document Type: Conference Paper

References (29)

1. UNAIDS, WHO. AIDS Epidemic Update: December 2000. Geneva: Joint United Nations Program on HIV/AIDS, 2000.
2. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV [erratum appears in 1997; 337(11):799]. N Engl J Med 1997; 336:1072-1078.
3. UNAIDS, WHO. Epidemiological Fact Sheet on HIV/AIDS and Sexually Transmitted Infections, 2000 Update. Geneva: Joint United Nations Program on HIV/AIDS, 2000.
4. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis [erratum appears in 1998; 352:2026]. Lancet 1998; 351(Suppl 3):5-7.
5. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
6. Røttingen J-A, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV How much is known? Sex Transm Dis 2001; 28:579-597.
7. WHO. Management of patients with sexually transmitted diseases. WHO Technical Report Series 1991:810.
8. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868-1873.
9. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381-387.
10. Gerbase AC, Rowley JT, Heymann DHL, Berkley SFB, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74(Suppl 1):s12-s16.
11. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995; 172:1371-1374.
12. Watson-Jones D, Mugeye K, Mayaud P, et al. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study. Sex Transm Infect 2000; 76:355-362.
13. Wilkinson D, Ndovela N, Harrison A, Lurie M, Connolly C, Sturm AW. Family planning services in developing countries: an opportunity to treat asymptomatic and unrecognized genital tract infections? Genitourin Med 1997; 73:558-560.
14. Zhang Z-F. Epidemiology of Trichomonas vaginalis: a prospective study in China. Sex Transm Dis 1996; 23:415-424.
15. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-174.
16. Lule G, Behets FM, Hoffman IF, et al. STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med 1994; 70:384-388.
17. Kaydos SC, Swygard H, Wise SL, et al. Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol 2002; 40:89-95.
18. Aral SO. Sexually transmitted diseases: magnitude, determinants and consequences. Intl J STD AIDS 2001; 12:211-215.
19. Holmes KK, et al. Etiology of non-gonococcal urethritis. N Engl J Med 1975; 292:1199.
20. Kreiger JN. Consider diagnosis and treatment of trichomoniasis in men. Sex Transm Dis 2000:241-242.
21. Morency P, Dubois MJ, Gresenguet G, et al. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect 2001; 77:125-129.
22. Pepin J, Sobela F, Deslandes S, et al. Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis. Bull World Health Organ 2001; 79:118-126.
23. Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844-849.
24. Kaydos S, Hobbs M, Price M, et al. Sites of Trichomonas vaginalis infection in the genitourinary tract of Malawian men. In: Proceedings of the Annual Meeting of the International Society for Sexually Transmitted Disease Researchers (ISSTDR). Berlin, Germany: 2001.
25. Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men: a randomized double-blind study. JAMA 1995; 274:545-549.
26. Hay PE, Thomas BJ, Gilchrist C, Palmer HM, Gilroy CB, TaylorRobinson D. A reappraisal of chlamydial and nonchlamydial acute non-gonococcal urethritis. Intl J STD AIDS 1992; 3:191-195.
27. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001; 15:837-845.
28. Taylor S, Sadiq T, Kaye S, et al. Prevalence of HIV-1 drug-transmitted resistance in semen of patients on HAART with acute sexually transmitted infections [abstract 373-M]. In: Proceedings of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA: 2002.
29. Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001; 15:621-627.